Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
To determine the outcome and safety of a combined antimicrobial treatment involving
daptomycin and surgical approach involving retention or short-interval two-stage exchange of
the implant. Patients with hip, knee and shoulder Prosthetic Joint Infection (PJI) caused by
methicillin-susceptible and methicillin-resistant staphylococci will be included and followed
during 2 years.
Phase:
Phase 2
Details
Lead Sponsor:
Andrej Trampuz
Collaborators:
Kantonsspital Liestal Schulthess Klinik University of Lausanne Hospitals